Latest Regulatory News

Bentley Capital Limited has voluntarily suspended trading of its shares on the ASX pending a market announcement addressing a recent price and volume query. The suspension is expected to last until early November, signaling heightened regulatory scrutiny.

Sarama Resources has formally filed a US$242 million damages claim against Burkina Faso following the expropriation of its Tankoro 2 Exploration Permit, marking a pivotal step in its international arbitration process.

Livium Ltd has been granted a patent protecting its innovative wet shredding process for lithium-ion battery recycling, enhancing safety and operational efficiency. This milestone solidifies its position in the evolving clean energy recycling sector.

Piche Resources Limited has voluntarily suspended trading of its shares pending a crucial update on its capital raising efforts, expected by early next week.

Petratherm Limited has initiated an extensive resource drilling program at its Rosewood Titanium Project, aiming to define a maiden JORC resource over a 40km area. Concurrent environmental baseline studies are also underway to support future mining applications.

Western Yilgarn NL has significantly expanded its exploration footprint at the Ida Holmes Junction Project to target high-grade gallium mineralisation and secured critical land access for drilling at its West Julimar Bauxite Project in Western Australia.

LCL Resources Limited faces suspension from ASX trading due to failure to lodge a required periodic report on time, raising questions about the company’s compliance and operational transparency.

Black Dragon Gold has withdrawn its application to classify the Salave Gold Project as a Project of Strategic Interest in Asturias, Spain, planning a stronger resubmission backed by legal clarity and community support.

Orthocell has completed its first Remplir™ surgical case in Hong Kong, marking a pivotal step in its Asian commercialisation strategy. The launch at the Hong Kong Orthopaedic Association Congress and partnership with MontsMed set the stage for broader regional growth.

Medallion Metals has advanced its Ravensthorpe Gold Project to the final stage of environmental assessment under the EPBC Act, with a decision expected by December 2025. This milestone is crucial for progressing its sulphide production strategy alongside ongoing state permits and a proposed acquisition.

Anteris Technologies has secured FDA approval to commence its pivotal PARADIGM clinical trial, testing its innovative DurAVR Transcatheter Heart Valve against established devices in patients with severe aortic stenosis.

JAYRIDE Group Limited is advancing its transformation into a scalable Mobility-as-a-Service platform, securing new funding and expanding its SaaS footprint across the Asia-Pacific region.